Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Urenco ChemPlants Read moreSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report01 June 2018
Urenco Limited is pleased to announce the appointment of Mel Kroon as Non-Executive Director, with effect 1 September 2018.
Mel will succeed George Verberg who will retire from the Board on 31 August 2018. The Board thanks George for his valuable contribution and support throughout his tenure.
Mel has been Chief Executive Officer of TenneT Holding B.V. since 2002 and will step down in August. Previous to that, he held the position of Managing Director at Hooge Huys Verzekeringen N.V. and served as Deputy Chair of the Executive Board of SNS Reaal Insurance.
His career started at Fokker Aircraft N.V., where he held a variety of posts including that of Vice President for Marketing. He then transferred, first to Holec N.V. as Director for Marketing and Sales of the Traction Division, then to the SNS Reaal Insurance Group.
Mel also serves in the capacity of Chairman Supervisory Board TenneT TSO GmbH and Chairman Supervisory Board HGRT S.A.
Other positions include Member of the Board Dutch-German Chamber of Commerce; Member of the Supervisory Board Coöperatie VGZ; Member Supervisory Board TKH Group N.V. and Member Supervisory Board Koole Terminals B.V.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries
Sign up to our newsletter by entering your email address below.